Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Marcos Hortes Nisihara Chagas is active.

Publication


Featured researches published by Marcos Hortes Nisihara Chagas.


Neuropsychopharmacology | 2011

Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients

Mateus M. Bergamaschi; Regina Helena Costa Queiroz; Marcos Hortes Nisihara Chagas; Danielle Chaves Gomes de Oliveira; Bruno Spinosa De Martinis; Flávio Kapczinski; João Quevedo; Rafael Roesler; Nadja Schröder; Antonio Egidio Nardi; R. Martin-Santos; Jaime Eduardo Cecílio Hallak; Antonio Waldo Zuardi; José Alexandre S. Crippa

Generalized Social Anxiety Disorder (SAD) is one of the most common anxiety conditions with impairment in social life. Cannabidiol (CBD), one major non-psychotomimetic compound of the cannabis sativa plant, has shown anxiolytic effects both in humans and in animals. This preliminary study aimed to compare the effects of a simulation public speaking test (SPST) on healthy control (HC) patients and treatment-naïve SAD patients who received a single dose of CBD or placebo. A total of 24 never-treated patients with SAD were allocated to receive either CBD (600 mg; n=12) or placebo (placebo; n=12) in a double-blind randomized design 1 h and a half before the test. The same number of HC (n=12) performed the SPST without receiving any medication. Each volunteer participated in only one experimental session in a double-blind procedure. Subjective ratings on the Visual Analogue Mood Scale (VAMS) and Negative Self-Statement scale (SSPS-N) and physiological measures (blood pressure, heart rate, and skin conductance) were measured at six different time points during the SPST. The results were submitted to a repeated-measures analysis of variance. Pretreatment with CBD significantly reduced anxiety, cognitive impairment and discomfort in their speech performance, and significantly decreased alert in their anticipatory speech. The placebo group presented higher anxiety, cognitive impairment, discomfort, and alert levels when compared with the control group as assessed with the VAMS. The SSPS-N scores evidenced significant increases during the testing of placebo group that was almost abolished in the CBD group. No significant differences were observed between CBD and HC in SSPS-N scores or in the cognitive impairment, discomfort, and alert factors of VAMS. The increase in anxiety induced by the SPST on subjects with SAD was reduced with the use of CBD, resulting in a similar response as the HC.


Alcoholism: Clinical and Experimental Research | 2010

Is the Full Version of the AUDIT Really Necessary? Study of the Validity and Internal Construct of Its Abbreviated Versions

Carolina de Meneses-Gaya; Antonio Waldo Zuardi; Sonia Regina Loureiro; Jaime Eduardo Cecílio Hallak; Clarissa Trzesniak; João Mazzoncini de Azevedo Marques; João Paulo Machado-de-Sousa; Marcos Hortes Nisihara Chagas; Roberto M. Souza; José Alexandre S. Crippa

BACKGROUND This study was aimed at assessing the psychometric qualities of the abbreviated versions of the Alcohol Use Disorders Identification Test (AUDIT-3, AUDIT-4, AUDIT-C, AUDIT-PC, AUDIT-QF, FAST, and Five-Shot) and at comparing them to the 10-item AUDIT and the CAGE in 2 samples of Brazilian adults. METHODS The validity and internal consistency of the scales were assessed in a sample of 530 subjects attended at an emergency department and at a Psychosocial Care Center for Alcohol and Drugs. The Structured Clinical Interview for DSM-IV was used as the diagnostic comparative measure for the predictive validity assessment. The concurrent validity between the scales was analyzed by means of Pearsons correlation coefficient. RESULTS The assessment of the predictive validity of the abbreviated versions showed high sensitivity (of 0.78 to 0.96) and specificity (of 0.74 to 0.94) indices, with areas under the curve as elevated as those of the AUDIT (0.89 and 0.92 to screen for abuse and 0.93 and 0.95 in the screening of dependence). The CAGE presented lower indices: 0.81 for abuse and 0.87 for dependence. The analysis of the internal consistency of the AUDIT and its versions exhibited Cronbachs alpha coefficients between 0.83 and 0.94, while the coefficient for the CAGE was 0.78. Significant correlations were found between the 10-item AUDIT and its versions, ranging from 0.91 to 0.99. Again, the results for the CAGE were satisfactory (0.77), although inferior to the other instruments. CONCLUSIONS The results obtained in this study confirm the validity of the abbreviated versions of the AUDIT for the screening of alcohol use disorders and show that their psychometric properties are as satisfactory as those of the 10-item AUDIT and the CAGE.


Journal of Clinical Pharmacy and Therapeutics | 2014

Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson's disease patients: A case series

Marcos Hortes Nisihara Chagas; Alan Luiz Eckeli; Antonio Waldo Zuardi; Márcio Alexandre Pena-Pereira; M. A. Sobreira‐Neto; Emmanuelle Silva Tavares Sobreira; M. R. Camilo; Mateus M. Bergamaschi; C. H. Schenck; J.E.C. Hallak; Vitor Tumas; José Alexandre S. Crippa

Cannabidiol (CBD) is the main non‐psychotropic component of the Cannabis sativa plant. REM sleep behaviour disorder (RBD) is a parasomnia characterized by the loss of muscle atonia during REM sleep associated with nightmares and active behaviour during dreaming. We have described the effects of CBD in RBD symptoms in patients with Parkinsons disease.


Schizophrenia Research | 2011

Are cavum septum pellucidum abnormalities more common in schizophrenia spectrum disorders? A systematic review and meta-analysis

Clarissa Trzesniak; Irismar Reis de Oliveira; Matthew J. Kempton; Amanda Galvão-de Almeida; Marcos Hortes Nisihara Chagas; Maria Cecília Freitas Ferrari; Alaor Santos Filho; Antonio Waldo Zuardi; Daniel Almeida Prado; Geraldo F. Busatto; P.K. McGuire; Jaime Eduardo Cecílio Hallak; José Alexandre S. Crippa

Magnetic resonance imaging (MRI) studies have reported a variety of brain abnormalities in association with schizophrenia. These include a higher incidence of cavum septum pellucidum (CSP), which is consistent with a neurodevelopmental model for this disorder. In this meta-analytic review, we describe and discuss the main CSP MRI findings in schizophrenia spectrum disorders (SSDs) to date. We adopted as keywords cavum and schizophrenia or psychosis, and the inclusion criteria were articles in English, with samples of SSD patients compared to healthy subjects, which used MRI to assess CSP, without time limit. From 18 potential reports, fifteen were eligible to be part of the current review. These studies included 1054 patients with SSD and 866 healthy volunteers. Six out of 15 studies pointed to a higher prevalence of CSP of any size in SSD patients, while five out of 15 showed that subjects with SSD had a greater occurrence of a large CSP than healthy individuals. However, the meta-analysis demonstrated that only the incidence of a large CSP was significantly higher in SSD relative to healthy comparisons (odds ratio=1.59; 95%CI 1.07-2.38; p=0.02). Overall our results suggest that only a large CSP is associated with SSD while a small CSP may be considered a normal neuroanatomical variation. Our review revealed a large degree of variability in the methods employed across the MRI studies published to date, as well as evidence of publication bias. Studies in large, community-based samples with greater standardization of methods should clarify the true significance of CSP in SSD.


Journal of Neuroscience Methods | 2010

Facial affect processing in social anxiety: Tasks and stimuli

João Paulo Machado-de-Sousa; Kátia C. Arrais; Nelson Torro Alves; Marcos Hortes Nisihara Chagas; Carolina de Meneses-Gaya; José Alexandre S. Crippa; Jaime Eduardo Cecílio Hallak

Social anxiety (SA) has as its main feature the fear of social situations, being characterized as social phobia or social anxiety disorder when functional impairment emerges as a result of that fear. Although the recognition of the condition has increased in recent years, it is believed that many patients and physicians still take the symptoms of the disorder for personality traits with no need for treatment. There is evidence that people with SA display abnormal patterns of facial emotion processing that could account for the onset and maintenance of the disorder. The objective of this review is to describe, compare, and discuss the methods used to study facial emotion processing in SA with an emphasis on the tasks and stimuli employed. Articles were searched for on online scientific databases. Forty research articles were selected according to the inclusion and exclusion criteria established. The articles were read and information from them was gathered on a comparative table for analysis. Evidence available to date suggests that SA individuals have abnormal patterns of facial information processing characterized by a bias for negative emotions. The results of the articles analyzed have a high degree of concordance, in spite of the variety of tasks and stimuli employed. The similarity between results from non-clinical samples with SA and patients affected by social phobia speaks in favor of the current view that SA occurs as a continuum of severity, rather than a clearly circumscribed nosological entity.


Journal of Psychopharmacology | 2011

Effects of cannabidiol on amphetamine-induced oxidative stress generation in an animal model of mania:

Samira S. Valvassori; Guilherme Alves Elias; Bruna de Souza; Fabricia Petronilho; Felipe Dal-Pizzol; Flávio Kapczinski; Clarissa Trzesniak; Vitor Tumas; Serdar M. Dursun; Marcos Hortes Nisihara Chagas; Jaime Eduardo Cecílio Hallak; Antonio Waldo Zuardi; João Quevedo; José Alexandre S. Crippa

Cannabidiol (CBD), a Cannabis sativa constituent, may present a pharmacological profile similar to mood stabilizing drugs, in addition to anti-oxidative and neuroprotective properties. The present study aims to directly investigate the effects of CBD in an animal model of mania induced by d-amphetamine (d-AMPH). In the first model (reversal treatment), rats received saline or d-AMPH (2 mg/kg) once daily intraperitoneal (i.p.) for 14 days, and from the 8th to the 14th day, they were treated with saline or CBD (15, 30 or 60 mg/kg) i.p. twice a day. In the second model (prevention treatment), rats were pretreated with saline or CBD (15, 30, or 60 mg/kg) regime i.p. twice a day, and from the 8th to the 14th day, they also received saline or d-AMPH i.p. once daily. In the hippocampus CBD (15 mg/kg) reversed the d-AMPH-induced damage and increased (30 mg/kg) brain-derived neurotrophic factor (BDNF) expression. In the second experiment, CBD (30 or 60 mg/kg) prevented the d-AMPH-induced formation of carbonyl group in the prefrontal cortex. In the hippocampus and striatum the d-AMPH-induced damage was prevented by CBD (15, 30 or 60 mg/kg). At both treatments CBD did not present any effect against d-AMPH-induced hyperactivity. In conclusion, we could not observe effects on locomotion, but CBD protect against d-AMPH-induced oxidative protein damage and increased BDNF levels in the reversal model and these effects vary depending on the brain regions evaluated and doses of CBD administered.


PLOS ONE | 2014

Increased Amygdalar and Hippocampal Volumes in Young Adults with Social Anxiety

João Paulo Machado-de-Sousa; Flávia de Lima Osório; Andrea Parolin Jackowski; Rodrigo Affonseca Bressan; Marcos Hortes Nisihara Chagas; Nelson Torro-Alves; André L. D. DePaula; José Alexandre S. Crippa; Jaime Eduardo Cecílio Hallak

Background Functional neuroimaging studies have consistently shown abnormal limbic activation patterns in socially anxious individuals, but structural data on the amygdala and hippocampus of these patients are scarce. This study explored the existence of structural differences in the whole brain, amygdala, and hippocampus of subjects with clinical and subthreshold social anxiety compared to healthy controls. We hypothesized that there would be volumetric differences across groups, without predicting their direction (i.e. enlargement or reduction). Methods Subjects classified as having social anxiety disorder (n = 12), subthreshold social anxiety (n = 12) and healthy controls (n = 14) underwent structural magnetic resonance imaging scans. The amygdala and hippocampus were defined a priori as regions of interest and volumes were calculated by manual tracing. Whole brain volume was calculated using voxel-based morphometry. Results The bilateral amygdala and left hippocampus were enlarged in socially anxious individuals relative to controls. The volume of the right hippocampus was enlarged in subthreshold social anxiety participants relative to controls. No differences were found across groups in respect to total brain volume. Conclusions Our results show amygdalar and hippocampal volume alterations in social anxiety, possibly associated with symptom severity. The time course of such alterations and the cellular and molecular bases of limbic plasticity in social anxiety should be further investigated.


Journal of Clinical Pharmacy and Therapeutics | 2013

Cannabidiol for the treatment of cannabis withdrawal syndrome: a case report

José Alexandre S. Crippa; J.E.C. Hallak; João Paulo Machado-de-Sousa; Regina Helena Costa Queiroz; Mateus M. Bergamaschi; Marcos Hortes Nisihara Chagas; Antonio Waldo Zuardi

What is known and Objective: Cannabis withdrawal in heavy users is commonly followed by increased anxiety, insomnia, loss of appetite, migraine, irritability, restlessness and other physical and psychological signs. Tolerance to cannabis and cannabis withdrawal symptoms are believed to be the result of the desensitization of CB1 receptors by THC.


Revista Brasileira de Psiquiatria | 2012

Neuroimaging in specific phobia disorder: a systematic review of the literature

Ila M. P. Linares; Clarissa Trzesniak; Marcos Hortes Nisihara Chagas; Jaime Eduardo Cecílio Hallak; Antonio Egidio Nardi; José Alexandre S. Crippa

OBJECTIVE Specific phobia (SP) is characterized by irrational fear associated with avoidance of specific stimuli. In recent years, neuroimaging techniques have been used in an attempt to better understand the neurobiology of anxiety disorders. The objective of this study was to perform a systematic review of articles that used neuroimaging techniques to study SP. METHOD A literature search was conducted through electronic databases, using the keywords: imaging, neuroimaging, PET, spectroscopy, functional magnetic resonance, structural magnetic resonance, SPECT, MRI, DTI, and tractography, combined with simple phobia and specific phobia. One-hundred fifteen articles were found, of which 38 were selected for the present review. From these, 24 used fMRI, 11 used PET, 1 used SPECT, 2 used structural MRI, and none used spectroscopy. RESULT The search showed that studies in this area were published recently and that the neuroanatomic substrate of SP has not yet been consolidated. CONCLUSION In spite of methodological differences among studies, results converge to a greater activation in the insula, anterior cingulate cortex, amygdala, and prefrontal and orbitofrontal cortex of patients exposed to phobia-related situations compared to controls. These findings support the hypotheses of the hyperactivation of a neuroanatomic structural network involved in SP.


Parkinsonism & Related Disorders | 2010

Validity of a Brazilian version of the Zung self-rating depression scale for screening of depression in patients with Parkinson's disease☆

Marcos Hortes Nisihara Chagas; Vitor Tumas; Sonia Regina Loureiro; Jaime Eduardo Cecílio Hallak; Clarissa Trzesniak; João Paulo Machado de Sousa; Guilherme Gustavo Ricciopo Rodrigues; Alaor Santos Filho; José Alexandre S. Crippa

INTRODUCTION Parkinsons disease (PD) is a neurodegenerative disorder with prominent motor manifestations and many other non-motor symptoms that significantly decrease quality-of-life and are frequently under-recognized, for example depression. OBJECTIVE To study the validity of a Brazilian version of the Zung Self-rating Depression Scale (SDS) for the diagnosis of depression in patients with PD. METHODS We evaluated 78 consecutive non demented patients over the age of 40 with diagnosis of PD at a Movement Disorders Outpatient Clinic, who could read and understand questionnaires. They completed the SDS and the Geriatric Depression Scale with 15 items (GDS-15). The diagnosis of depression was made after a structured clinical interview based on DSM-IV criteria for the diagnosis of major depression (SCID-CV). RESULTS The prevalence of major depression was 23.1%. Cronbachs alpha was 0.73 and the area under the ROC curve was 0.93 for the SDS. The score index of 55 had a sensitivity of 88.9% and a specificity of 83.3% for the diagnosis of depression. The total scores of the SDS and GDS-15 were highly correlated (0.652, p < 0.0001) and correlated weakly with the scores of a motor scale. DISCUSSION The SDS is a valid tool for screening depression in patients with PD since the specific SDS index of 55 is adopted. Two shortened versions could be used with good results.

Collaboration


Dive into the Marcos Hortes Nisihara Chagas's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Vitor Tumas

University of São Paulo

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Antonio Egidio Nardi

Federal University of Rio de Janeiro

View shared research outputs
Top Co-Authors

Avatar

João Quevedo

University of Texas Health Science Center at Houston

View shared research outputs
Top Co-Authors

Avatar

Giovanni Abrahão Salum

Universidade Federal do Rio Grande do Sul

View shared research outputs
Researchain Logo
Decentralizing Knowledge